Extramedullary Myeloid Cell Tumors in Myelodysplastic-Syndromes: Not a True Indication of Impending Acute Myeloid Leukemia
Authors:
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 21 (1-2) , 153-159
Abstract
The purpose of this report is to record a patient with myelodysplastic syndrome (MDS) associated acute myelogenous leukemia (AML) and leukemia cutis who had blast expression of the neural cell adhesion molecule (NCAM) and to review the world literature on prognostic implications of extramedullary myeloid cell tumors (granulocytic sarcoma, myeloblastoma, chloroma and leukemia cutis) in MDS and MDS associated AML. Case report and world literature from January 1965-January 1994 for all cases of MDS-associated extramedullary myeloid cell tumors (EMT) is reviewed, and the first patient with EMT, MDS associated AML and blast expression of NCAM is described. There have been 46 cases of MDS associated EMT previously reported. 32 cases occurred in the absence of AML. AML developed in 47% of these patients at a mean of 38 weeks from initial EMT. Of the patients not developing AML, median survival from initial EMT was 11 weeks. Nine patients received chemotherapy at the time of EMT and had a median survival of 36 weeks. The median survival for patients receiving conservative therapy for EMT was 48 weeks. Patients (n = 15) with EMT and MDS associated AML had a poor outcome regardless of therapy with a median survival of 11 weeks. Unlike other forms of isolated EMT, MDS associated EMT is not always a forerunner of AML. Premature induction therapy for MDS associated EMT does not appear to prolong survival. EMT in the setting of MDS associated AML is associated with a poor prognosis despite aggressive chemotherapy. Blast expression of NCAM may prove to be a risk factor for EMT in MDS associated AML.Keywords
This publication has 43 references indexed in Scilit:
- Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion moleculeCancer, 1994
- Leukemia Cutis:Analysis of 50 Biopsy-Proven Cases With an Emphasis on Occurrence in Myelodysplastic SyndromesAmerican Journal of Clinical Pathology, 1993
- Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia.Journal of Clinical Oncology, 1993
- Myeloblastoma formation in acute myeloid leukemiaLeukemia Research, 1992
- Granulocytic sarcoma in myelodysplastic syndromes: Clinical marker of disease accelerationThe American Journal of Medicine, 1991
- High Risk Subgroup of Acute Myelomonocytic Leukemia (AMML) with Orbito-Ocular Granulocytic Sarcoma (OOGS) in Turkish ChildrenActa Haematologica, 1989
- Granulocytic sarcoma in nonleukemic patientsCancer, 1986
- Isolated granulocytic sarcoma: report of a case and review of the literature.Journal of Clinical Oncology, 1986
- Clinicopathologic correlations in leukemia cutisJournal of the American Academy of Dermatology, 1984
- Aleukemic leukemia cutis: Juvenile chronic granulocytic leukemia presenting with figurate cutaneous lesionsJournal of the American Academy of Dermatology, 1983